Houston, USA-based privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, EndoQuest Robotics, announced the closure of C1 financing with USD 42 million. The company announced the funding on December 4, 2023. The company’s legacy investors, CE Ventures Limited and McNair Interests Ltd., led the financing for the company. Meanwhile, Puma Venture Capital LLC, as a new investor, provided the investment.
Purpose of financing for EndoQuest Robotics
With the latest strategic funding, the company seeks to fuel the advancement of its groundbreaking flexible endoluminal robot aimed at transforming minimally invasive procedures.
The significant investment reflects a strong vote of confidence in EndoQuest’s vision. It seeks to revolutionize endoluminal procedures through cutting-edge robotic technology. With the newly acquired capital, the company seeks to drive key initiatives, such as further research and development regulatory milestones. It also has plans to fund commercialization efforts. Meanwhile, the company intends to bolster its position as the frontrunner in flexible endoluminal robotics.
What the company’s official has to add
Kurt Azarbarzin, CEO of EndoQuest Robotics, further said, “Our investors share our vision of leveraging robotics to redefine the possibilities in minimally invasive procedures. This financing enables us to continue innovating and refining our technology, ultimately improving patient care and transforming the future of endoluminal interventions.”
What the investors have to comment
Neeraj Agrawal, Executive Director of Crescent Enterprises, said, “The EndoQuest team is trailblazing novel solutions in minimally invasive surgery. We welcome our new partners and remain fully supportive of the Company and the prospects to transform healthcare with our innovative endoluminal surgical platform.”
In addition, Amit Hazan, Co-Founder and Managing Partner of Puma Venture Capital LLC and Dr. Vipul Patel, a world-renowned robotic urologic surgeon as well as the Co-Founder and Senior Venture Partner of Puma Venture Capital LLC added, “We are thrilled to join CE Ventures and McNair Interests in this funding round for EndoQuest Robotics. I’ve had the privilege of seeing just about every robotic surgical system either in development or on the market today and can honestly say that EndoQuest’s system is a true game changer for both physicians and patients.”
About EndoQuest Robotics
EndoQuest Robotics is a pioneer in the innovative development of transformative endoluminal robotic technologies. The Company seeks to revolutionise minimally invasive procedures by creating cutting-edge endoluminal interventions tailored for therapeutic endoscopists and surgeons. It helps them to perform upper and lower gastrointestinal surgery less invasively with a focus on enhancing precision, flexibility, and patient outcomes.
To explore more such startups, visit Zefyron Startup Database
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
